Xiaoyun L. Lu
Guangzhou, 510515, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 138 publications
Exploring the efficacy and safety profile of the use of a heparin-free integrated tandem pre-flushing method for DPMAS treatment in patients with liver failure
Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Published: September 07, 2026
Advances in the diagnosis and treatment of patients with multidrug-resistant bacterial infections combined with severe liver disease
Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Published: June 29, 2026
Generative Replica Exchange: A Flow-Based Framework for Accelerating Replica-Exchange Simulations.
Journal: Journal of chemical theory and computation
Published: June 24, 2026
Dual-Site Covalent Targeting Enables BD2-Selective BET Inhibition With Potent Antitumor Activity in Mice.
Journal: Angewandte Chemie (International ed. in English)
Published: April 04, 2026
Discovery of 4-((2S,5R)-2-((difluoromethoxy)methyl)-5-(4-(trifluoromethyl)phenyl)piperidin-1-yl)-N-((R)-1-(4-(ethylsulfonyl)phenyl)-2-hydroxyethyl)benzamide as a potent, orally available RORγt inverse agonist.
Journal: Bioorganic chemistry
Published: March 22, 2026
Discovery of a Potent RXRγ Degrader WCF-598 for the Treatment of Castration-Resistant Prostate Cancer.
Journal: Journal of medicinal chemistry
Published: March 20, 2026
Structure-Based Design of 4-(1-Methyl-1H-indol-3-yl)pyrimidin-2-amine Derivatives as the First Covalent FGFR3 Selective Inhibitors.
Journal: Journal of medicinal chemistry
Published: February 06, 2026
Opportunities and challenges in the development of evolving EGFR inhibitors to overcome EGFR TKIs resistance.
Journal: Acta pharmacologica Sinica
Published: January 22, 2026
Recent advances in HER2-targeted inhibitors for cancer therapy.
Journal: Pharmaceutical science advances
Published: January 16, 2026
Structure-Based Virtual Screening Discovers Potent PLK1 Inhibitors with Anticancer Activity.
Journal: Journal of chemical information and modeling
Published: January 06, 2026
Design, Synthesis, and Biological Evaluation of the First Novel Macrocycle-Based FGFR Inhibitors That Overcome Clinically Acquired Resistance.
Journal: Journal of medicinal chemistry
Published: January 06, 2026
Large-Scale Profiling of Kinase Degradation by Using Norbornene-Based Hydrophobic Tag (HyT) Strategy.
Journal: Angewandte Chemie (International ed. in English)
Published: December 18, 2025
Last Updated: 09/26/2026